Can high-dose aflibercept satisfy unmet treatment needs in diabetic macular oedema?

MeSH terms

• Angiogenesis Inhibitors / therapeutic use
• Diabetes Mellitus* / drug therapy
• Diabetic Retinopathy* / drug therapy
• Humans
• Macular Edema* / drug therapy
• Ranibizumab
• Receptors, Vascular Endothelial Growth Factor / therapeutic use
• Recombinant Fusion Proteins / therapeutic use
• Tomography, Optical Coherence
• Treatment Outcome